News Archive

Listed below are our archived news items

2013

The latest anti-immunisation Facebook claims about Gardasil being a huge scam are just a rehash of an old 2009 story published as 'news' by a British tabloid.

Health Minister Tony Ryall reported a significant improvement in New Zealand's immunisation rates for children by their second birthday.

The Syrian Arab Republic, polio-free since 1999, have confirmed cases of wild poliovirus.

All District Health Boards (DHBs) offer free influenza immunisation to their staff. Uptake of the immunisation increased to 58% of the DHB workforce in 2013 compared with 48% in 2012.

The Therapeutic Goods Administration has licensed the Novartis meningococcal B vaccine Bexsero for use in Australia.

The Ministry of Health is enabling the National Immunisation Register (NIR) to collect information on the 11 year old Tdap immunisation event.

Written for high school science and history classes, covering the birth of vaccines in the late 1700s through to cutting-edge approaches to novel vaccines and vaccine delivery.

PHARMAC have extended the eligibility criteria for free influenza vaccine from 1 April 2013.

The packaging for ProPharma supplied Boostrix® will be changing.

The European Commission has approved a new vaccine (Bexsero®) that provides broad protection against meningococcal group B disease.

2012

PHARMAC have extended the availability of funded Boostrix® for pregnant women between 28-38 weeks gestation from 1 January 2013.

The whooping cough vaccine is available for family/whānau of infants less than one year of age who are already accessing specified immunisation services.

Eligibilty for funded National Immunisation Schedule childhood catch-up vaccines has been extended for adolescents to their 18th birthday, in line with the Health and Disability Services Eligibility Direction 2011.

The packaging for Synflorix® and Infanrix®-IPV is changing. The vaccine formulations have not changed.

South Canterbury will be commencing a school-based Gardasil® programme for 12 year old girls from term one 2013.

The Centers for Disease Control and Prevention in the US is coordinating a multistate investigation of fungal meningitis among patients who received a particular medication injected into the spine.

Pfizer have announced top-line data assessing immunogenicity, tolerability and safety of Prevenar 13® in adults aged 18-49 years of age.

Toi Te Ora - Public Health Service have children singing about immunisation on radio.

Researchers at the University of Otago are inching closer to the development of the first effective oral vaccine to protect against tuberculosis (TB).

The Ministry of Health has released the updated cold chain management guidelines.

2011

As of 9 May 2013, GSK have advised that they are continuing to make Rotarix available to patients at a significantly reduced price through the Rotarix patient access programme to at least the end of 2013.

The immunisation programme ended on December 16th 2011. An estimated 31,455 Northlanders are belived to have taken up the offer of free vaccine against the serious disease.

The Ministry of Health declined to fund a nationwide meningococcal C immunisation programme due to the high cost involved.

A 45 year old woman was admitted to Whangarei Hospital yesterday with suspected meningococcal disease. She has no clear links to the Northlnad children diagnosed with the disease earlier this month.

Rubella is a significant disease for pregnant women. It can have severe effects on the unborn child, including deafness, blindness, brain damage and heart defects.

Auckland Regional Public Health Service advised that two cases of rubella have been confirmed in the past week.

A second child was admitted to Whangarei Hospital on 10 August with menignococcal disease. Their condition is stable.

In New Zealand a single dose of either brand of varicella vaccine in children under the age of 13 years is likely to be adequate because there is a lot of wild virus circulating that will boost immunity.